Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

prognostic marker

  • You have access
    Preoperative and Postoperative C-Reactive Protein to Albumin Ratio (CAR) as a Prognostic Marker for Survival of Esophageal Squamous Cell Carcinoma Patients After Surgery
    SHINICHI ASAKA, TAKESHI SHIMAKAWA, RYOHEI NISHIGUCHI, KENTARO YAMAGUCHI, MINORU MURAYAMA, TAKEBUMI USUI, HAJIME YOKOMIZO and SHUNICHI SHIOZAWA
    Anticancer Research November 2023, 43 (11) 5139-5147; DOI: https://doi.org/10.21873/anticanres.16714
  • Open Access
    High Expression of CD58 and ALDH1A3 Predicts a Poor Prognosis in Basal-like Breast Cancer
    YUYUN XIONG, HITOMI MOTOMURA, SHOMA TAMORI, AYAKA OZAKI, CHOTARO ONAGA, YASUSHI HARA, KEIKO SATO, KOUJI TAHATA, YOHSUKE HARADA, KAZUNORI SASAKI, YUN-WEN ZHENG, SHIGEO OHNO and KAZUNORI AKIMOTO
    Anticancer Research November 2022, 42 (11) 5223-5232; DOI: https://doi.org/10.21873/anticanres.16029
  • Open Access
    High Expression of p62 and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer
    AYAKA OZAKI, HITOMI MOTOMURA, SHOMA TAMORI, CHOTARO ONAGA, YUKA NAGASHIMA, MAHO KOTORI, CHIKA MATSUDA, AKARI MATSUDA, NANAKO MOCHIZUKI, TSUGUMICHI SATO, YASUSHI HARA, KEIKO SATO, YOHEI MIYAGI, YOJI NAGASHIMA, TAKEHISA HANAWA, YOHSUKE HARADA, YUYUN XIONG, KAZUNORI SASAKI, SHIGEO OHNO and KAZUNORI AKIMOTO
    Anticancer Research July 2022, 42 (7) 3299-3312; DOI: https://doi.org/10.21873/anticanres.15818
  • You have access
    Outcome Prediction After Neoadjuvant Chemotherapy (NAC) for Breast Cancer, Using Tumor-infiltrating Lymphocytes Within Fibrotic Foci of Tumor Stroma (FF-TILs)
    SHINICHIRO KASHIWAGI, YUKA ASANO, KOJI TAKADA, WATARU GOTO, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA, KOSEI HIRAKAWA and MASAICHI OHIRA
    Anticancer Research March 2022, 42 (3) 1421-1431; DOI: https://doi.org/10.21873/anticanres.15612
  • You have access
    Prognostic Value of Copine 1 in Patients With Renal Cell Carcinoma
    IMAN M. TALAAT, EMAN ABU-GHARBIEH, AMAL HUSSEIN, MAHMOOD HACHIM, ISRAA SOBHY, MOHAMED ELADL and WASEEM EL-HUNEIDI
    Anticancer Research January 2022, 42 (1) 355-362; DOI: https://doi.org/10.21873/anticanres.15493
  • You have access
    The Prognostic Significance of Plakophilin-1 Expression in Esophageal Cancer
    JUNKI FUJITA, MASANOBU NAKAJIMA, HIROTO MUROI, MAIKO KIKUCHI, KEISUKE IHARA, TAKESHI YAMAGUCHI, MASATOSHI NAKAGAWA, SHINJI MORITA, TAKATOSHI NAKAMURA, TAKASHI TSUCHIOKA and KAZUYUKI KOJIMA
    Anticancer Research July 2021, 41 (7) 3401-3407; DOI: https://doi.org/10.21873/anticanres.15127
  • You have access
    High SLC20A1 Expression Is Associated With Poor Prognoses in Claudin-low and Basal-like Breast Cancers
    CHOTARO ONAGA, SHOMA TAMORI, HITOMI MOTOMURA, AYAKA OZAKI, CHIKA MATSUDA, IZUMI MATSUOKA, TAKUMA FUJITA, YUKA NOZAKI, YASUSHI HARA, YOHEI KAWANO, YOHSUKE HARADA, TSUGUMICHI SATO, YASUNARI MANO, KEIKO SATO and KAZUNORI AKIMOTO
    Anticancer Research January 2021, 41 (1) 43-54; DOI: https://doi.org/10.21873/anticanres.14750
  • You have access
    Clinical Significance of Tumour CD44v and MIST1 Expression in Patients With Non-small-cell Lung Cancer
    TAKUYA NAGASHIMA, TAKASHI OSHIMA, YUKIHIKO HIROSHIMA, TOMOYUKI YOKOSE, TETSUKAN WOO, YASUSHI RINO, MUNETAKA MASUDA, YOHEI MIYAGI, HIROYUKI ITO and HARUHIKO NAKAYAMA
    Anticancer Research November 2020, 40 (11) 6407-6416; DOI: https://doi.org/10.21873/anticanres.14662
  • You have access
    ARID3A Positivity Correlated With Favorable Prognosis in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy
    GHILSUK YOON, JEE YOUNG PARK, HYE JIN KIM, GYU SEOG CHOI, JONG GWANG KIM, BYUNG WOOG KANG, MIN KYU KANG and AN NA SEO
    Anticancer Research June 2019, 39 (6) 2845-2853; DOI: https://doi.org/10.21873/anticanres.13413
  • You have access
    Prognostic Value of Quality of Life in Endocrine Therapy for Elderly Patients With Breast Cancer: A Retrospective Study
    KOJI TAKADA, SHINICHIRO KASHIWAGI, YUKA ASANO, WATARU GOTO, KATSUYUKI TAKAHASHI, MASATSUNE SHIBUTANI, RYOSUKE AMANO, TSUTOMU TAKASHIMA, SHUHEI TOMITA, KOSEI HIRAKAWA and MASAICHI OHIRA
    Anticancer Research June 2019, 39 (6) 2941-2950; DOI: https://doi.org/10.21873/anticanres.13424

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire